GLUTASIM 3MG Tablet by Saffron Pharma contains Semaglutide 3mg, an oral GLP-1 receptor agonist used as part of a comprehensive treatment plan for adults with type 2 diabetes. It works alongside a healthy diet and regular physical activity to help improve blood glucose control.
Semaglutide can help the body respond more effectively to glucose by enhancing glucose-dependent insulin release, reducing inappropriate glucagon secretion, and slowing gastric emptying. It may also reduce appetite and food intake.
GLUTASIM 3MG is an oral tablet and should be used strictly according to the prescribing instructions provided by a qualified healthcare professional.
GLUTASIM 3MG Tablet is an oral medicine containing:
Semaglutide belongs to a group of medicines known as GLP-1 receptor agonists. Oral semaglutide is primarily used to help manage blood glucose levels in adults with type 2 diabetes when prescribed by a healthcare professional.
Semaglutide can help improve blood glucose control as part of an overall diabetes-management plan.
It works by activating GLP-1 receptors involved in blood glucose regulation, insulin secretion, appetite and digestion.
Semaglutide helps stimulate insulin secretion when blood glucose levels are elevated.
It can reduce glucagon secretion in a glucose-dependent manner, helping regulate blood sugar levels.
Semaglutide slows the movement of food from the stomach, which can influence glucose absorption and contribute to increased fullness.
GLP-1 receptor activity can influence appetite and food intake, although individual responses vary.
As an oral tablet, GLUTASIM offers a tablet-based alternative to injectable GLP-1 medicines when oral semaglutide is appropriate.
Semaglutide is structurally related to the naturally occurring hormone GLP-1 (glucagon-like peptide-1).
It acts on GLP-1 receptors in the body and produces several effects:
1. Increases insulin secretion when blood glucose is elevated
This helps the body lower blood glucose after meals and during periods of elevated glucose.
2. Reduces glucagon secretion
Glucagon normally signals the liver to release glucose. Semaglutide reduces inappropriate glucagon secretion when glucose levels are high.
3. Delays gastric emptying
Food moves more slowly from the stomach, which can affect the rate at which glucose enters the bloodstream.
4. Influences appetite
Semaglutide may increase feelings of fullness and reduce food intake in some people.
Your doctor may prescribe oral semaglutide as part of treatment for:
The exact indication depends on the approved product labeling and your healthcare provider's assessment.
GLUTASIM should not be used as a substitute for medical advice, prescribed diabetes treatment, or a healthy lifestyle.
This medicine may be considered for adults with type 2 diabetes who:
Your doctor will determine whether semaglutide is appropriate based on your medical history, current medicines, blood glucose levels and treatment goals.
| Active Ingredient | Strength | Function |
|---|---|---|
| Semaglutide | 3mg | GLP-1 receptor agonist that helps regulate blood glucose |
Oral semaglutide has specific administration requirements because food and other medicines can affect its absorption.
For oral semaglutide, 3mg is commonly used as an initial treatment strength before a higher maintenance strength is considered. Do not increase the dose yourself.
If you forget to take your daily tablet, follow the missed-dose instructions provided with your prescribed product.
Do not take two doses together to make up for a missed dose.
If you frequently forget doses, discuss this with your healthcare provider or pharmacist.
Like all medicines, semaglutide may cause side effects. Gastrointestinal effects are among the most commonly reported.
These effects may be more noticeable when treatment is started or the dose is increased.
Contact your healthcare provider promptly if you develop:
Before using GLUTASIM, tell your doctor if you:
Medicines containing semaglutide carry an important thyroid C-cell tumor warning. Tell your healthcare provider if you have a personal or family history of medullary thyroid carcinoma (MTC) or Multiple Endocrine Neoplasia syndrome type 2 (MEN 2).
Tell your doctor or pharmacist about all medicines you take, particularly:
Because oral semaglutide can affect gastric emptying and has specific administration requirements, your healthcare provider may need to review the timing of other oral medicines.
If you are pregnant, planning to become pregnant, or breastfeeding, speak with your doctor before using GLUTASIM.
Semaglutide is generally not used for weight-loss purposes during pregnancy, and treatment decisions during pregnancy should be made by a qualified healthcare professional.
If you become pregnant while taking semaglutide, contact your healthcare provider.
GLUTASIM itself does not usually directly impair driving, but low blood sugar can affect concentration and coordination, particularly when semaglutide is used with insulin or sulfonylureas.
If you experience dizziness, weakness, blurred vision or symptoms of hypoglycemia, avoid driving and seek appropriate medical advice.
Contains Semaglutide 3mg, a GLP-1 receptor agonist used in type 2 diabetes management.
Provides semaglutide in an oral dosage form rather than an injectable preparation.
Each pack contains 10 tablets, making it convenient for dispensing and treatment planning.
GLUTASIM is manufactured by Saffron Pharma.
Sample/Placeholder Reviews – for demonstration only
⭐⭐⭐⭐⭐ Ali R. – Lahore
"Ordering was straightforward, and the medicine arrived securely packed."
⭐⭐⭐⭐⭐ Hassan M. – Karachi
"Good service from SuperCare Pharma and the order was delivered promptly."
⭐⭐⭐⭐⭐ Usman K. – Islamabad
"The ordering process was simple and the product packaging was secure."
| Product Information | Details |
|---|---|
| Brand | GLUTASIM |
| Manufacturer | Saffron Pharma |
| Generic | Semaglutide |
| Strength | 3mg |
| Dosage Form | Tablet |
| Pack Size | 10 Tablets |
| Medicine Type | Prescription Medicine |
| Drug Class | GLP-1 Receptor Agonist |
GLUTASIM 3MG contains semaglutide and may be prescribed as part of a treatment plan for adults with type 2 diabetes to help improve blood glucose control.
Each tablet contains Semaglutide 3mg.
Oral semaglutide is generally taken once daily on an empty stomach with a small amount of plain water. Wait at least 30 minutes before eating, drinking anything other than water, or taking other oral medicines.
Semaglutide can affect appetite and body weight, but GLUTASIM should only be used for the indication and purpose prescribed by your healthcare provider. Do not use prescription semaglutide for weight loss without medical supervision.
Common side effects can include nausea, diarrhea, vomiting, constipation, abdominal discomfort and decreased appetite. Contact your doctor if symptoms are severe or persistent.
Choose SuperCare Pharma for a convenient online pharmacy experience in Pakistan.
✔ Genuine pharmaceutical products
✔ Secure online ordering
✔ Convenient nationwide delivery
✔ Carefully packed orders
✔ Competitive pricing
✔ Customer support
GLUTASIM is a prescription medicine. Use it only according to the advice of a qualified healthcare professional.
Looking for GLUTASIM 3MG Tablet (Semaglutide) by Saffron Pharma? Order through SuperCare Pharma for a convenient online pharmacy experience and delivery across Pakistan.
Always use semaglutide according to your doctor's instructions and do not change the dose without professional medical advice.
